Global AI for Clinical and Molecular Diagnostics Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Software
1.2.3 Services
1.2.4 Hardware
1.3 Market by Application
1.3.1 Global AI for Clinical and Molecular Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical Diagnostics
1.3.3 Molecular Diagnostics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI for Clinical and Molecular Diagnostics Market Perspective (2021–2032)
2.2 Global AI for Clinical and Molecular Diagnostics Growth Trends by Region
2.2.1 Global AI for Clinical and Molecular Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI for Clinical and Molecular Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 AI for Clinical and Molecular Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 AI for Clinical and Molecular Diagnostics Market Dynamics
2.3.1 AI for Clinical and Molecular Diagnostics Industry Trends
2.3.2 AI for Clinical and Molecular Diagnostics Market Drivers
2.3.3 AI for Clinical and Molecular Diagnostics Market Challenges
2.3.4 AI for Clinical and Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI for Clinical and Molecular Diagnostics Players by Revenue
3.1.1 Global Top AI for Clinical and Molecular Diagnostics Players by Revenue (2021–2026)
3.1.2 Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top AI for Clinical and Molecular Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI for Clinical and Molecular Diagnostics Revenue
3.4 Global AI for Clinical and Molecular Diagnostics Market Concentration Ratio
3.4.1 Global AI for Clinical and Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI for Clinical and Molecular Diagnostics Revenue in 2025
3.5 Global Key Players of AI for Clinical and Molecular Diagnostics Head Offices and Areas Served
3.6 Global Key Players of AI for Clinical and Molecular Diagnostics, Products and Applications
3.7 Global Key Players of AI for Clinical and Molecular Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI for Clinical and Molecular Diagnostics Breakdown Data by Type
4.1 Global AI for Clinical and Molecular Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Type (2027–2032)
5 AI for Clinical and Molecular Diagnostics Breakdown Data by Application
5.1 Global AI for Clinical and Molecular Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI for Clinical and Molecular Diagnostics Market Size (2021–2032)
6.2 North America AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI for Clinical and Molecular Diagnostics Market Size by Country (2021–2026)
6.4 North America AI for Clinical and Molecular Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI for Clinical and Molecular Diagnostics Market Size (2021–2032)
7.2 Europe AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2021–2026)
7.4 Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI for Clinical and Molecular Diagnostics Market Size (2021–2032)
9.2 Latin America AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (2021–2026)
9.4 Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche AI for Clinical and Molecular Diagnostics Introduction
11.1.4 Roche Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Fujifilm
11.2.1 Fujifilm Company Details
11.2.2 Fujifilm Business Overview
11.2.3 Fujifilm AI for Clinical and Molecular Diagnostics Introduction
11.2.4 Fujifilm Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.2.5 Fujifilm Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina AI for Clinical and Molecular Diagnostics Introduction
11.3.4 Illumina Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.3.5 Illumina Recent Development
11.4 GE HealthCare
11.4.1 GE HealthCare Company Details
11.4.2 GE HealthCare Business Overview
11.4.3 GE HealthCare AI for Clinical and Molecular Diagnostics Introduction
11.4.4 GE HealthCare Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.4.5 GE HealthCare Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips AI for Clinical and Molecular Diagnostics Introduction
11.5.4 Philips Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.5.5 Philips Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic AI for Clinical and Molecular Diagnostics Introduction
11.6.4 Medtronic Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.6.5 Medtronic Recent Development
11.7 Microsoft
11.7.1 Microsoft Company Details
11.7.2 Microsoft Business Overview
11.7.3 Microsoft AI for Clinical and Molecular Diagnostics Introduction
11.7.4 Microsoft Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.7.5 Microsoft Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Details
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers AI for Clinical and Molecular Diagnostics Introduction
11.8.4 Siemens Healthineers Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.8.5 Siemens Healthineers Recent Development
11.9 Intel
11.9.1 Intel Company Details
11.9.2 Intel Business Overview
11.9.3 Intel AI for Clinical and Molecular Diagnostics Introduction
11.9.4 Intel Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.9.5 Intel Recent Development
11.10 Enlitic
11.10.1 Enlitic Company Details
11.10.2 Enlitic Business Overview
11.10.3 Enlitic AI for Clinical and Molecular Diagnostics Introduction
11.10.4 Enlitic Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.10.5 Enlitic Recent Development
11.11 NVIDIA
11.11.1 NVIDIA Company Details
11.11.2 NVIDIA Business Overview
11.11.3 NVIDIA AI for Clinical and Molecular Diagnostics Introduction
11.11.4 NVIDIA Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.11.5 NVIDIA Recent Development
11.12 Qure AI
11.12.1 Qure AI Company Details
11.12.2 Qure AI Business Overview
11.12.3 Qure AI AI for Clinical and Molecular Diagnostics Introduction
11.12.4 Qure AI Revenue in AI for Clinical and Molecular Diagnostics Business (2021–2026)
11.12.5 Qure AI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Software
Table 3. Key Players of Services
Table 4. Key Players of Hardware
Table 5. Global AI for Clinical and Molecular Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 8. Global AI for Clinical and Molecular Diagnostics Market Share by Region (2021–2026)
Table 9. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global AI for Clinical and Molecular Diagnostics Market Share by Region (2027–2032)
Table 11. AI for Clinical and Molecular Diagnostics Market Trends
Table 12. AI for Clinical and Molecular Diagnostics Market Drivers
Table 13. AI for Clinical and Molecular Diagnostics Market Challenges
Table 14. AI for Clinical and Molecular Diagnostics Market Restraints
Table 15. Global AI for Clinical and Molecular Diagnostics Revenue by Players (US$ Million), 2021–2026
Table 16. Global AI for Clinical and Molecular Diagnostics Market Share by Players (2021–2026)
Table 17. Global Top AI for Clinical and Molecular Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI for Clinical and Molecular Diagnostics Revenue, 2025
Table 18. Ranking of Global Top AI for Clinical and Molecular Diagnostics Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by AI for Clinical and Molecular Diagnostics Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of AI for Clinical and Molecular Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of AI for Clinical and Molecular Diagnostics, Products and Applications
Table 22. Global Key Players of AI for Clinical and Molecular Diagnostics, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global AI for Clinical and Molecular Diagnostics Market Size by Type (US$ Million), 2021–2026
Table 25. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Type (2021–2026)
Table 26. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Type (2027–2032)
Table 28. Global AI for Clinical and Molecular Diagnostics Market Size by Application (US$ Million), 2021–2026
Table 29. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Application (2021–2026)
Table 30. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Application (2027–2032)
Table 32. North America AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 34. North America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 35. Europe AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 37. Europe AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche AI for Clinical and Molecular Diagnostics Product
Table 50. Roche Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 51. Roche Recent Development
Table 52. Fujifilm Company Details
Table 53. Fujifilm Business Overview
Table 54. Fujifilm AI for Clinical and Molecular Diagnostics Product
Table 55. Fujifilm Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 56. Fujifilm Recent Development
Table 57. Illumina Company Details
Table 58. Illumina Business Overview
Table 59. Illumina AI for Clinical and Molecular Diagnostics Product
Table 60. Illumina Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 61. Illumina Recent Development
Table 62. GE HealthCare Company Details
Table 63. GE HealthCare Business Overview
Table 64. GE HealthCare AI for Clinical and Molecular Diagnostics Product
Table 65. GE HealthCare Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 66. GE HealthCare Recent Development
Table 67. Philips Company Details
Table 68. Philips Business Overview
Table 69. Philips AI for Clinical and Molecular Diagnostics Product
Table 70. Philips Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 71. Philips Recent Development
Table 72. Medtronic Company Details
Table 73. Medtronic Business Overview
Table 74. Medtronic AI for Clinical and Molecular Diagnostics Product
Table 75. Medtronic Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 76. Medtronic Recent Development
Table 77. Microsoft Company Details
Table 78. Microsoft Business Overview
Table 79. Microsoft AI for Clinical and Molecular Diagnostics Product
Table 80. Microsoft Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 81. Microsoft Recent Development
Table 82. Siemens Healthineers Company Details
Table 83. Siemens Healthineers Business Overview
Table 84. Siemens Healthineers AI for Clinical and Molecular Diagnostics Product
Table 85. Siemens Healthineers Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 86. Siemens Healthineers Recent Development
Table 87. Intel Company Details
Table 88. Intel Business Overview
Table 89. Intel AI for Clinical and Molecular Diagnostics Product
Table 90. Intel Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 91. Intel Recent Development
Table 92. Enlitic Company Details
Table 93. Enlitic Business Overview
Table 94. Enlitic AI for Clinical and Molecular Diagnostics Product
Table 95. Enlitic Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 96. Enlitic Recent Development
Table 97. NVIDIA Company Details
Table 98. NVIDIA Business Overview
Table 99. NVIDIA AI for Clinical and Molecular Diagnostics Product
Table 100. NVIDIA Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 101. NVIDIA Recent Development
Table 102. Qure AI Company Details
Table 103. Qure AI Business Overview
Table 104. Qure AI AI for Clinical and Molecular Diagnostics Product
Table 105. Qure AI Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 106. Qure AI Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report


List of Figures
Figure 1. AI for Clinical and Molecular Diagnostics Picture
Figure 2. Global AI for Clinical and Molecular Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global AI for Clinical and Molecular Diagnostics Market Share by Type: 2025 vs 2032
Figure 4. Software Features
Figure 5. Services Features
Figure 6. Hardware Features
Figure 7. Global AI for Clinical and Molecular Diagnostics Market Size by Application (US$ Million), 2021–2032
Figure 8. Global AI for Clinical and Molecular Diagnostics Market Share by Application: 2025 vs 2032
Figure 9. Clinical Diagnostics Case Studies
Figure 10. Molecular Diagnostics Case Studies
Figure 11. AI for Clinical and Molecular Diagnostics Report Years Considered
Figure 12. Global AI for Clinical and Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global AI for Clinical and Molecular Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global AI for Clinical and Molecular Diagnostics Market Share by Region: 2025 vs 2032
Figure 15. Global AI for Clinical and Molecular Diagnostics Market Share by Players in 2025
Figure 16. Global AI for Clinical and Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by AI for Clinical and Molecular Diagnostics Revenue in 2025
Figure 18. North America AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 20. United States AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 24. Germany AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Share by Region (2021–2032)
Figure 32. China AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 40. Mexico AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 44. Israel AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Roche Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 48. Fujifilm Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 49. Illumina Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 50. GE HealthCare Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 51. Philips Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 52. Medtronic Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 53. Microsoft Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 54. Siemens Healthineers Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 55. Intel Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 56. Enlitic Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 57. NVIDIA Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 58. Qure AI Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit